Capital Management Corp VA Buys 4,780 Shares of CME Group Inc. $CME

Capital Management Corp VA lifted its stake in CME Group Inc. (NASDAQ:CME) by 15.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 35,187 shares of the financial services provider’s stock after buying an additional 4,780 shares during the quarter. CME Group comprises 1.5% of Capital Management Corp VA’s portfolio, making the stock its 26th biggest holding. Capital Management Corp VA’s holdings in CME Group were worth $9,507,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in CME Group by 1.5% during the second quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock valued at $9,695,313,000 after purchasing an additional 532,549 shares in the last quarter. Geode Capital Management LLC raised its position in shares of CME Group by 3.6% during the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock valued at $2,524,271,000 after purchasing an additional 319,899 shares during the period. Norges Bank bought a new stake in shares of CME Group during the 2nd quarter valued at $1,571,447,000. Ameriprise Financial Inc. lifted its stake in shares of CME Group by 2.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock valued at $1,289,910,000 after buying an additional 92,925 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in CME Group by 6.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock worth $1,056,476,000 after buying an additional 238,522 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Down 0.3%

NASDAQ CME opened at $289.06 on Friday. The stock has a 50 day moving average price of $275.25 and a 200-day moving average price of $272.33. CME Group Inc. has a one year low of $233.66 and a one year high of $291.76. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $104.24 billion, a P/E ratio of 28.01, a P/E/G ratio of 3.26 and a beta of 0.27.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend was Friday, December 12th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Wall Street Analyst Weigh In

A number of research firms have commented on CME. Raymond James Financial raised their price target on CME Group from $307.00 to $311.00 and gave the company an “outperform” rating in a report on Monday, January 5th. TD Cowen raised CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. UBS Group restated a “neutral” rating on shares of CME Group in a research note on Tuesday, January 6th. Rothschild & Co Redburn lifted their price objective on shares of CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a research report on Thursday, November 6th. Finally, Bank of America boosted their target price on shares of CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $292.18.

Insider Transactions at CME Group

In related news, Director William R. Shepard acquired 251 shares of CME Group stock in a transaction on Tuesday, December 30th. The shares were bought at an average cost of $278.37 per share, with a total value of $69,870.87. Following the completion of the purchase, the director directly owned 258,710 shares of the company’s stock, valued at $72,017,102.70. The trade was a 0.10% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the sale, the director owned 1,091 shares in the company, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.